| Manager - Risk & Assurance |
Moscow (City) |
Russian Fed. |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Δεκ 13, 2024 |
| Hematology Area Manager |
Novosibirsk |
Russian Fed. |
International |
Innovative Medicines |
Sales |
Δεκ 01, 2024 |
| Key Account Manager |
Krasnoyarsk |
Russian Fed. |
International |
Innovative Medicines |
Sales |
Νοε 29, 2024 |
| Key Account Manager |
Yaroslavl |
Russian Fed. |
International |
Innovative Medicines |
Sales |
Νοε 29, 2024 |
| Key Account Manager |
Tyumen |
Russian Fed. |
International |
Innovative Medicines |
Sales |
Νοε 29, 2024 |
| Key Account Manager |
Stavropol |
Russian Fed. |
International |
Innovative Medicines |
Sales |
Νοε 28, 2024 |
| Key Account Manager |
Irkutsk |
Russian Fed. |
International |
Innovative Medicines |
Sales |
Νοε 26, 2024 |
| Key Account Manager |
Irkutsk |
Russian Fed. |
International |
Innovative Medicines |
Sales |
Νοε 13, 2024 |
| Senior Product Manager |
Moscow (City) |
Russian Fed. |
International |
Innovative Medicines |
Marketing |
Νοε 13, 2024 |
| Региональный коммерческий менеджер |
Vladimir |
Russian Fed. |
International |
Innovative Medicines |
Sales |
Νοε 05, 2024 |
| R2R Accountant |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
Οκτ 22, 2024 |
| Специалист по системе качества |
St. Petersburg (City) |
Russian Fed. |
Operations |
Innovative Medicines |
Quality |
Οκτ 22, 2024 |
| H2R Services Expert |
Moscow (City) |
Russian Fed. |
People & Organization |
CTS |
Human Resources |
Οκτ 16, 2024 |
| H2R Services Expert |
Moscow (City) |
Russian Fed. |
People & Organization |
CTS |
Human Resources |
Οκτ 15, 2024 |
| Key Account Manager |
Novokuznetsk |
Russian Fed. |
International |
Innovative Medicines |
Sales |
Σεπ 25, 2024 |
| Medical Science Liaison Hemato (Siberia) |
Novosibirsk |
Russian Fed. |
International |
Innovative Medicines |
Research & Development |
Σεπ 20, 2024 |
| Treasury Manager |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
Ιουν 20, 2024 |